Results 111 to 120 of about 186,499 (128)
Some of the next articles are maybe not open access.
Ceroid Lipofuscinosis Type 2 (CLN2) is caused by inherited tripeptidyl peptidase 1 (TPP1) enzyme deficiency. The main treatment is a biweekly intracerebroventricular enzyme replacement therapy (ICV-ERT) of recombinant human TPP1 (cerliponase alfa).
Harriet Chang +5 more
openaire +1 more source
Harriet Chang +5 more
openaire +1 more source
CerliponaseĀ alfa not recommended by NICE for Batten disease
PharmacoEconomics & Outcomes News, 2019openaire +1 more source

